Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients.

2.50
Hdl Handle:
http://hdl.handle.net/10541/108080
Title:
Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients.
Authors:
Thatcher, Nick; Wan, H H; Swindell, Ric; Wilkinson, Peter M; Crowther, Derek
Abstract:
The effects of a single Phenytoin dose, given to patients with malignant melanoma, upon peripheral blood counts, serum immunoglobulins, lymphocyte subpopulations and lymphocytotoxicity (using Chang target cells) were recorded. Sequential blood samples were taken before and 10, 14, 34, 38 and 58 h after the Phenytoin. Early reductions (P less than 0.05) in lymphocyte count, NK, K and PHA induced cytotoxicity, when compared with initial, pre-Phenytoin values were noted. Immunisation with i.v. C. parvum prevented the reductions occurring after a second dose of Phenytoin. Indeed, significant increases above the values of samples taken immediately before the second dose, were observed in T cells, PHA blastogenesis, NK and K cell Cytotoxicity. The second dose did however cause some immunosuppression; the increase in T cells, NK and PHA induced cytotoxicity above initial values expected from previous investigations were not observed. The immunosuppression, particularly of killer cell function, occurring after phenytoin could have implications for the pathogenesis of malignancy and transplacental carcinogenesis, reported as following Phenytoin exposure.
Affiliation:
Cancer Research Campaign Department of Medical Oncology, England.
Citation:
Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients. 1982, 4 (3):167-74 Int J Immunopharmacol
Journal:
International Journal of Immunopharmacology
Issue Date:
1982
URI:
http://hdl.handle.net/10541/108080
DOI:
10.1016/0192-0561(82)90045-5
PubMed ID:
7107099
Type:
Article
Language:
en
ISSN:
0192-0561
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorThatcher, Nicken
dc.contributor.authorWan, H Hen
dc.contributor.authorSwindell, Ricen
dc.contributor.authorWilkinson, Peter Men
dc.contributor.authorCrowther, Dereken
dc.date.accessioned2010-07-21T14:04:31Z-
dc.date.available2010-07-21T14:04:31Z-
dc.date.issued1982-
dc.identifier.citationEffects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients. 1982, 4 (3):167-74 Int J Immunopharmacolen
dc.identifier.issn0192-0561-
dc.identifier.pmid7107099-
dc.identifier.doi10.1016/0192-0561(82)90045-5-
dc.identifier.urihttp://hdl.handle.net/10541/108080-
dc.description.abstractThe effects of a single Phenytoin dose, given to patients with malignant melanoma, upon peripheral blood counts, serum immunoglobulins, lymphocyte subpopulations and lymphocytotoxicity (using Chang target cells) were recorded. Sequential blood samples were taken before and 10, 14, 34, 38 and 58 h after the Phenytoin. Early reductions (P less than 0.05) in lymphocyte count, NK, K and PHA induced cytotoxicity, when compared with initial, pre-Phenytoin values were noted. Immunisation with i.v. C. parvum prevented the reductions occurring after a second dose of Phenytoin. Indeed, significant increases above the values of samples taken immediately before the second dose, were observed in T cells, PHA blastogenesis, NK and K cell Cytotoxicity. The second dose did however cause some immunosuppression; the increase in T cells, NK and PHA induced cytotoxicity above initial values expected from previous investigations were not observed. The immunosuppression, particularly of killer cell function, occurring after phenytoin could have implications for the pathogenesis of malignancy and transplacental carcinogenesis, reported as following Phenytoin exposure.en
dc.language.isoenen
dc.subject.meshBacterial Vaccines-
dc.subject.meshCytotoxicity, Immunologic-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshImmunoglobulin G-
dc.subject.meshImmunotherapy-
dc.subject.meshKiller Cells, Natural-
dc.subject.meshLymphocytes-
dc.subject.meshMale-
dc.subject.meshMelanoma-
dc.subject.meshPhenytoin-
dc.subject.meshPhytohemagglutinins-
dc.subject.meshPropionibacterium acnes-
dc.subject.meshRosette Formation-
dc.titleEffects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients.en
dc.typeArticleen
dc.contributor.departmentCancer Research Campaign Department of Medical Oncology, England.en
dc.identifier.journalInternational Journal of Immunopharmacologyen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.